A preview of what's genuinely new. Sign up for your full, always-current stack.
LiteraturePediatricsSep 14, 2026
Pediatric Firearm ED Visits Rose During Pandemic, Stayed Elevated Through 2023A retrospective study using the Pediatric Health Information System examined firearm injury-related emergency department visits among patients under 18 from 2016 to 2023, identifying 6358 such visits. The study reported that visits increased from an average of 44.1 per month in 2016 to 83.3 in 2023, with an early pandemic surge in 2020 followed by no significant linear change but persistently elevated volumes. The authors noted that while hospitalization and mortality counts rose, their proportions remained stable, suggesting the increase reflected rising injury incidence rather than increased severity.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
LiteratureJAMA PediatricsSep 14, 2026
South Korean study finds stable autism prevalence across birth cohortsA prospective population-based screening and diagnostic study of 12 consecutive birth cohorts in South Korea (children born 1998-2010, assessed at age 7) reported that 7-year cumulative incidence and prevalence of autism spectrum disorder remained stable over time, ranging from 1.9% to 3.2% for incidence and 2.0% to 3.4% for prevalence, with no statistically significant increase or decrease. The study also found that female children with ASD were disproportionately represented among previously undiagnosed cases identified in general education settings and showed distinct phenotypic profiles and substantial unmet clinical needs. The authors state these findings suggest detection-related factors may contribute substantially to reported increases in ASD occurrence estimates seen in administrative or service-based data.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Recall / safety alertFDA Drug Enforcement ReportsSep 9, 2026
Class II recall: Baxter Healthcare Corporation: Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 Baxter Healthcare Corporation has issued a Class II recall for Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), supplied in GALAXY 50 mL Single Dose Containers (NDC 0338-4114-50), the FDA reports. The recall was initiated due to current Good Manufacturing Practice (CGMP) deviations, according to the notice. No additional clinical or patient outcome details were specified in the source.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Recall / safety alertFDA Drug Enforcement ReportsSep 9, 2026
Class II recall: Baxter Healthcare Corporation: Clindamycin Injection USP in 5% Dextrose, 600 mg per 50 mL (12 mg/mL) in GALAXY The FDA has classified as Class II a recall by Baxter Healthcare Corporation of Clindamycin Injection USP in 5% Dextrose, 600 mg per 50 mL (12 mg/mL), supplied in GALAXY 50 mL Single Dose Containers (NDC 0338-3612-50). The recall notice cites current good manufacturing practice (CGMP) deviations as the reason for the action.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Recall / safety alertFDA Drug Enforcement ReportsSep 9, 2026
Class II recall: Baxter Healthcare Corporation: Vancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL (5 mg/mL) in GBaxter Healthcare Corporation has issued a Class II recall of Vancomycin Injection, USP, in 0.9% Sodium Chloride (1g per 200 mL, 5 mg/mL) supplied in GALAXY Single-Dose Containers, NDC 0338-3583-01. According to the recall notice, the action was initiated due to CGMP deviations. The product is Rx only and labeled sterile nonpyrogenic, manufactured by Baxter Healthcare Corporation of Deerfield, IL.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.